Clinical Trial Search block Test
An Open-Label Extension Study to Assess the Long-Term Safety And Efficacy Of Dupilumab In Patients =6 Months To <18 Years Of Age With Atopic Dermatitis
1434_OLE
What is the goal of the study?
To learn more about this study, please email the study team member listed below.
Who can participate in the study?
Everyone